| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827059 | Transplantation Proceedings | 2018 | 5 Pages |
Abstract
Due to its comparable HCC recurrence rate and superior long-term HRQoL scores relative to other radical therapies, RFA may be the first-choice treatment for solitary early-stage HCC.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Q. He, J.J. Jiang, Y.X. Jiang, W.T. Wang, L. Yang, Liver Surgery Group Liver Surgery Group,